Integrative genomic profiling of human prostate cancer.
- B. Taylor, N. Schultz, W. Gerald
- Biology, MedicineCancer Cell
- 13 July 2010
Integrative Clinical Genomics of Advanced Prostate Cancer
- D. Robinson, E. Allen, A. Chinnaiyan
- Medicine, BiologyCell
- 1 May 2015
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
- A. G. Robertson, Jaegil Kim, E. Zwarthoff
- BiologyCell
- 19 October 2017
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
- H. Moch, A. Cubilla, P. Humphrey, V. Reuter, T. Ulbright
- MedicineEuropean Urology
- 1 July 2016
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
- W. Linehan, P. Spellman, R. Zuna
- Medicine, BiologyNew England Journal of Medicine
- 14 January 2016
Type 1 and type 2 papillary renal-cell carcinomas were shown to be different types of renal cancer characterized by specific genetic alterations, with type 2 further classified into three individual subgroups on the basis of molecular differences associated with patient survival.
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
- Gabriele Campanella, M. Hanna, Thomas J. Fuchs
- Computer ScienceNature Network Boston
- 15 July 2019
A multiple instance learning-based deep learning system that uses only the reported diagnoses as labels for training, thereby avoiding expensive and time-consuming pixel-wise manual annotations, and has the ability to train accurate classification models at unprecedented scale.
The Molecular Taxonomy of Primary Prostate Cancer
- Adam Abeshouse, Jaeil Ahn, Douglas Voet
- Biology, MedicineCell
- 1 November 2015
Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions: A Sensitive and Specific Immunohistochemical Assay
- P. Argani, P. Lal, B. Hutchinson, M. Y. Lui, V. Reuter, M. Ladanyi
- Biology, MedicineAmerican Journal of Surgical Pathology
- 1 June 2003
The finding in the set of test cases that morphologic features can be used to predict TFE3 immunoreactivity further supports the notion that renal carcinomas with T FE3 gene fusions have a distinctive morphology that corresponds to their genetic distinctiveness.
Genomic correlates of clinical outcome in advanced prostate cancer
- W. Abida, J. Cyrta, C. Sawyers
- Medicine, BiologyProceedings of the National Academy of Sciences
- 6 May 2019
This large analysis integrating mCRPC genomics with histology and clinical outcomes identifies RB1 genomic alteration as a potent predictor of poor outcome, and is a community resource for further interrogation of clinical and molecular associations.
...
...